| Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks A Mendyk, PK Tuszyński, S Polak, R Jachowicz Drug design, development and therapy 7, 223, 2013 | 29 | 2013 |
| Transparent computational intelligence models for pharmaceutical tableting process MH Khalid, PK Tuszyński, P Kazemi, J Szlek, R Jachowicz, A Mendyk Complex Adaptive Systems Modeling 4, 2194-3206, 2016 | 16 | 2016 |
| Development of In Vitro-In Vivo Correlation/Relationship Modeling Approaches for Immediate Release Formulations Using Compartmental Dynamic Dissolution Data from “Golem”: A … M Čulen, PK Tuszyński, S Polak, R Jachowicz, A Mendyk, J Dohnal BioMed Research International 2015, 2015 | 10 | 2015 |
| From black-box to transparent computational intelligence models: a pharmaceutical case study MH Khalid, PK Tuszynski, J Szlek, R Jachowicz, A Mendyk 2015 13th International Conference on Frontiers of Information Technology …, 2015 | 8 | 2015 |
| In vitro-in vivo correlation (IVIVC): From current achievements towards the future PK Tuszyński, J Szlęk, S Polak, R Jachowicz, A Mendyk Dissolution Technologies 25 (3), 2018 | 6 | 2018 |
| How-To: Empirical IVIVR Without Intravenous Data A Mendyk, PK Tuszyński, MH Khalid, R Jachowicz, S Polak Dissolution Technologies 22 (2), 2015 | 5 | 2015 |
| From in vitro-in vivo relationship (IVIVR) towards in vitro-in vivo extrapolation (IVIVE): A case study of pulmonary delivery systems PK Tuszyński, S Polak, R Jachowicz, A Mendyk Dissolution Technologies, 32-35, 2017 | 3 | 2017 |
| Leki pierwszego wyboru PK Tuszyński Wydawnictwo Farmaceutyczne, 2023 | | 2023 |
| Zdrowie kobiety z perspektywy farmaceuty PK Tuszyński Wydawnictwo Farmaceutyczne, 2022 | | 2022 |
| Choroby zakaźne, którym można zapobiegać poprzez szczepienia PK Tuszyński, M Byliniak, E Żmudzka Kraków: Wydawnictwo Farmaceutyczne, 2020 | | 2020 |
| Extension of IVIVC Level A for risperidone in rabbits based on artificial intelligence (AI) A Mendyk, PK Tuszynski JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS 41, 59-59, 2018 | | 2018 |
| Cytotoxic activity of saponin fractions from selected species of the Chenopodiaceae family PK Tuszyński, M Kaleta, A Galanty, I Podolak International Conference on Saponins "New trends in saponins", Nancy, France, 2009 | | 2009 |
| Analiza fizykochemiczna i aktywność biologiczna wybranych gatunków z rodziny Chenopodiaceae A Czechura, M Dziewirz, M Kaleta, PK Tuszyński International Medical Students' Conference, Cracow, Poland, 2009 | | 2009 |
| Choroby dróg oddechowych II Wydanie, PK Tuszyński | | |
| Leki oczne i schorzenia okulistyczne I Wydanie, PK Tuszyński | | |
| Probiotyki i prebiotyki I Wydanie, PK Tuszyński | | |
Mohammad Hassan KhalidAstraZenecaGeverifieerd e-mailadres voor astrazeneca.com
